University of Washington Tacoma UW Tacoma Digital Commons SIAS Faculty Publications School of Interdisciplinary Arts and Sciences 2017 Modulators of IgG Penetration Through the Blood- Brain Barrier: Implications for Alzheimer's Disease Immunotherapy John M. Finke University of Washington Tacoma,
[email protected] William A. Banks Follow this and additional works at: https://digitalcommons.tacoma.uw.edu/ias_pub Recommended Citation Finke, John M. and Banks, William A., "Modulators of IgG Penetration Through the Blood-Brain Barrier: Implications for Alzheimer's Disease Immunotherapy" (2017). SIAS Faculty Publications. 825. https://digitalcommons.tacoma.uw.edu/ias_pub/825 This Article is brought to you for free and open access by the School of Interdisciplinary Arts and Sciences at UW Tacoma Digital Commons. It has been accepted for inclusion in SIAS Faculty Publications by an authorized administrator of UW Tacoma Digital Commons. Title: Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer’s Disease immunotherapy. Authors: John M. Finke1 and William A. Banks2,3 Affiliations: 1Division of Sciences and Mathematics, Interdisciplinary Arts and Sciences, University of Washington Tacoma, Tacoma, WA, USA 2Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA 3Division of Gerontology and Geriatric Medicine, Department of Geriatric Medicine, University of Washington School of Medicine, Seattle, WA, USA Introduction: Antibody drugs represent a viable treatment option for cancer and autoimmune conditions [43,65,74,95,109,146]. However, the future of antibody therapeutics in the treatment of central nervous system (CNS) disorders remains unclear. This uncertainty is underscored by a growing list of antibody drug trials that failed to meet clinical endpoints in the treatment of Alzheimer’s disease (AD) and multiple sclerosis (MS) [43,51,54,86,102,126].